Prisma Health-Upstate

Quick facts

Marketed products

• AmnioExCel dressing and compression therapy · Wound Care / Dermatology
  AmnioExCel is an amniotic membrane-derived wound dressing that promotes tissue healing and reduces inflammation when combined with compression therapy for chronic wounds.
• Intracervical injection of Vasopressin · Gynecology
  Vasopressin acts as a vasoconstrictor that reduces bleeding by constricting blood vessels in the cervix when injected directly into cervical tissue.
• Liposomal bupivacaine left injection · Anesthesia / Pain Management
  Liposomal bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.
• Liposomal bupivacaine right injection
• Standard Opioid · Pain Management
  Standard opioids bind to opioid receptors in the central and peripheral nervous system to reduce pain perception and produce analgesia.
• Standard opioid plus methocarbamol · Pain Management
  This combination product pairs an opioid analgesic with methocarbamol, a skeletal muscle relaxant, to provide pain relief and reduce muscle tension.

Phase 3 pipeline

• Gemcitabine/ clindamycin · Oncology
  This combination pairs gemcitabine, a nucleoside analog that disrupts DNA synthesis in rapidly dividing cells, with clindamycin, a lincosamide antibiotic that inhibits bacterial protein synthesis.

Phase 2 pipeline

• antibiotic rinse with suction

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Prisma Health-Upstate portfolio CI brief
• Prisma Health-Upstate pipeline updates RSS